Medical Care
New York State's González-Rojas Bill Ensures Kids' 6-Year Healthcare
2024-11-26
Children in New York State are now set to enjoy continuous healthcare coverage from birth until the age of six. This significant development comes after a bill introduced by Queens Assembly Member Jessica González-Rojas and State Sen. Samra Brouk of Rochester was passed in the state budget. The bill, A8146/S7747, which was introduced in October 2023, aimed to simplify enrollment in Child Health Plus and Medicaid, ensuring that the youngest New Yorkers have uninterrupted access to healthcare.

Expanding Healthcare Access for New York's Youngest

Benefits of Continuous Healthcare Coverage

Providing continuous coverage for children aged six and under leads to a multitude of benefits. A Georgetown University study found that it results in better health, reduced school absenteeism, and improved academic performance. Extended coverage for children can potentially lead to fewer lost work days for parents and reduced medical debt. Even a short gap in coverage can result in a child missing needed care for chronic conditions like asthma, which can lead to emergency room visits and missed school days.

New York is now one of seven states to offer this continuous coverage, and more than 800,000 children under the age of six are enrolled in Medicaid or Child Health Plus and could benefit. This change will mean less absences in childcare or school for our little ones and fewer missed days at work for parents, as stated by González-Rojas. Brouk, on the other hand, said the bill "lifts the burden of annual re-enrollment" by offering continuous healthcare coverage to children aged six or under. This legislation will support parents by giving children access to preventative care without interruptions, reducing barriers in healthcare and ensuring that our young people receive the care they deserve.

Support for the Legislation

New York Legal Assistance Group (NYLAG), Community Service Society (CSS), the Schuyler Center for Analysis and Advocacy, Medicaid Matters NY, the NYC Health and Hospitals System, the Robin Hood Foundation, SEIU 1199, and SEIU Doctors Council all supported the legislation when it was introduced last year. Kate Breslin, president and CEO at the Schuyler Center for Analysis and Advocacy, stated that uninterrupted healthcare coverage can provide several benefits for children and their families. Parents can access regular check-ups, scheduled vaccines, and preventive health services for their child, setting them up for a healthy start. Continuous Medicaid and CHP coverage is a big win for children and families across the state and ensures that New York will remain a leader in providing affordable, comprehensive health insurance coverage for children.

Arlington Capital Buys TEAM Technologies for Healthcare Portfolio
2024-11-26
Arlington Capital has made a significant move in the healthcare sector by acquiring TEAM Technologies. This acquisition is set to strengthen their healthcare portfolio and enhance supply chain capabilities. Let's delve deeper into the details.

Arlington Capital's Strategic Healthcare Acquisition

Acquisition Details

Private equity firm Arlington Capital has recently sealed a deal to acquire US-based medical device manufacturer TEAM Technologies from Clearlake Capital. TEAM Tech specializes in manufacturing and supply chain solutions, offering end-to-end outsourced design and manufacturing services to medical device and pharmaceutical OEMs. It has been focusing on advanced medical devices crucial for healthcare systems.Arlington Capital managing partner Matt Altman emphasized that TEAM Tech is dedicated to providing holistic solutions for healthcare OEMs' design and manufacturing needs while strengthening supply chains to ensure the timely delivery of critical goods.Arlington principal Gordon Auduong expressed excitement about working with TEAM Tech's management team and building on its foundation through organic investment and strategic acquisitions.TEAM Tech CEO Marshall White, with 25 years of experience, believes Arlington is the ideal partner to accelerate the company's growth and take it to the next level.

Arlington's Fund and Previous Investments

Arlington is currently investing from its $3.8bn VI Fund and has made investments in over 175 companies across healthcare, aerospace, and business service sectors since 1999. Recent healthcare investments include Afton Scientific, Riverpoint Medical, and Grand River Aseptic Manufacturing.

Other Healthcare PE Deals This Month

In addition to the TEAM Technologies acquisition, other healthcare PE deals have been making waves. Charme Capital Partners acquired Germany-headquartered biotech Centogene for around $9m, and Nexxus Iberia's PE Fund II secured a majority stake in Spanish diagnostic imaging company Vivo Diagnostico.Arlington enlisted Harris Williams as financial advisor and Goodwin Procter LLP as the legal adviser during the buy-up process of TEAM Tech.Access the most comprehensive Company Profiles on the market powered by GlobalData. Save hours of research and gain a competitive edge. You can view profiles in store and request a free sample by submitting the form. We are confident in the unique quality of our Company Profiles and want you to make the best decision for your business.Sign up for our daily news round-up to give your business an edge with our leading industry insights.
See More
GE HealthCare Launches Pristina Via Mammography System
2024-11-26
GE HealthCare has made a significant stride in the field of mammography with the unveiling of Pristina Via. This innovative mammography system is designed to enhance the screening experience for both technologists and patients. It offers a suite of tools that strike a balance between diagnostic accuracy and fast-moving workflows, enabling more patient-centered breast care.

Revolutionize Mammography with Pristina Via

Enhancing the Screening Experience

Pristina Via gives mammography technologists a powerful set of tools. It allows them to operate at their own pace without waiting between exposures, reducing stress and increasing efficiency. Vendor-neutral prior image comparison also saves time in analyzing previous exams, making final assessments more accurate. This focus on efficiency enables technologists to provide quality and individualized care during the screening process.The system is part of the Senographe Pristina platform, bringing features that help reduce repetitive tasks and simplify workflows. By minimizing laborious tasks, technologists are gifted with more time to prioritize what matters most: compassionate, patient-centered care.

Collaborative Innovation in Imaging

Earlier this month, GE HealthCare collaborated with DeepHealth, a subsidiary of RadNet. Together, they codeveloped SmartTechnology, which employs AI to address key obstacles across the imaging value chain. This includes increasing the efficiency of imaging interpretation and reporting, facilitating collaboration across care teams, improving the clinical interpretation of images, and strengthening operational efficiency and productivity.In October, GE HealthCare unveiled CareIntellect for Oncology. This cloud application combines multimodal patient data from different systems into a single view with the help of generative AI. It gives clinicians access to notes and reports, enhancing their ability to provide comprehensive care.In July, GE HealthCare formed a strategic partnership with Amazon Web Services (AWS). They will use AWS healthcare and genAI services to create AI-enabled workflows that improve the accuracy of diagnostic screening, streamline healthcare operations, and improve equitable care access and outcomes. GE will use Amazon Bedrock's foundation models to create its own proprietary genAI applications and modernize its applications built on Amazon SageMaker. The company's developers will also use Amazon Q, an AI-powered assistant, to generate code suggestions and assist in software development.

Competitive Landscape in Mammography

In September, Siemens Healthineers, GE HealthCare's competitor in the mammography space, received premarket approval from the FDA for the tomosynthesis or three-dimensional breast imaging technology of the Mammomat B.brilliant. This approval included new 3D image acquisition and image reconstruction technology, adding to the system's already-cleared features for full-field digital mammography, breast biopsy, and titanium contrast-enhanced mammography. This shows the intense competition in the mammography market and GE HealthCare's continuous efforts to stay at the forefront.
See More